Our portfolio covers a variety of formulation types such as solutions, (nano)suspensions, liposomes, lipid-based systems, biodegradable microspheres, injectable biodegradable rods, drug-device combinations, and other advanced drug delivery platforms. We explore a wide range of administration routes — oral, IV, IT, IM, SC, intra-organ, intra-tumoral, transmucosal, transdermal, nasal, ophthalmic — supporting both systemic drug delivery and local or targeted drug delivery approaches to address unmet patient needs. Apply best practices in formulation, characterization, validation, scale up, transfer, and compliant documentation in electronic lab notebooks and data systems; ensuring compliance with GMP, SHE (Safety, Health & Environment), and internal regulatory standards. Openness to utilizing modern digital tools and
more